These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39398931)

  • 1. Primary mediastinal choriocarcinoma in a woman treated with VIP therapy instead of BEP therapy for the prevention of postoperative acute respiratory distress syndrome.
    Aida Y; Watanabe R; Nakazawa K; Kobayashi N; Kawahara T; Kawai H; Sekine I; Hizawa N
    Int Cancer Conf J; 2024 Oct; 13(4):445-448. PubMed ID: 39398931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Extragonadal Germ Cell Tumor Treated by Induction Therapy with A Reduced Bep Regimen].
    Owa S; Sasaki T; Ishihara M; Watanabe S; Kato M; Sugino Y; Kato M; Masui S; Nishikawa K; Yoshio Y; Kanda H; Sugimura Y; Inoue T
    Hinyokika Kiyo; 2020 Dec; 66(12):449-452. PubMed ID: 33435656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer study.
    Kaye SB; Mead GM; Fossa S; Cullen M; deWit R; Bodrogi I; van Groeningen C; Sylvester R; Collette L; Stenning S; De Prijck L; Lallemand E; deMulder P
    J Clin Oncol; 1998 Feb; 16(2):692-701. PubMed ID: 9469359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study.
    Nichols CR; Catalano PJ; Crawford ED; Vogelzang NJ; Einhorn LH; Loehrer PJ
    J Clin Oncol; 1998 Apr; 16(4):1287-93. PubMed ID: 9552027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modified BEP regimen leads to abatement of choriocarcinoma syndrome in a patient with extra gonadal germ cell tumor : a case report].
    Oshima J; Uemura M; Kato T; Nagahara A; Kiuchi H; Tsujimura A; Nonomura N
    Hinyokika Kiyo; 2014 Apr; 60(4):183-7. PubMed ID: 24882231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
    Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
    Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of primary mediastinal choriocarcinoma].
    Yamane T; Egawa H; Deguchi N; Moritani C
    Nihon Kokyuki Gakkai Zasshi; 2006 Jan; 44(1):48-54. PubMed ID: 16502867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EORTC 30974).
    Daugaard G; Skoneczna I; Aass N; De Wit R; De Santis M; Dumez H; Marreaud S; Collette L; Lluch JRG; Bokemeyer C; Schmoll HJ
    Ann Oncol; 2011 May; 22(5):1054-1061. PubMed ID: 21059637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
    Mardiak J; Sálek T; Sycová-Milá Z; Obertová J; Recková M; Mego M; Hlavatá Z; Brozmanová K; Risnyovzská Z; Svetlovská D; Koza I
    Neoplasma; 2007; 54(3):240-5. PubMed ID: 17447857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary retroperitoneal pure choriocarcinoma].
    Okubo Y; Fukui I; Sakano Y; Yoshimura K; Maeda H; Yonese J; Yamauchi T; Kawai T; Okumura S; Ishikawa Y
    Nihon Hinyokika Gakkai Zasshi; 1995 Dec; 86(12):1784-8. PubMed ID: 8717221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.
    de Wit R; Stoter G; Sleijfer DT; Neijt JP; ten Bokkel Huinink WW; de Prijck L; Collette L; Sylvester R
    Br J Cancer; 1998 Sep; 78(6):828-32. PubMed ID: 9743309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Pulmonary Choriocarcinoma Treated With Neoadjuvant Chemotherapy and Lobectomy: A Case Report.
    Dlewati MM; Gonzalez T; Razi SS; Hussain SF; Bennett J
    Cureus; 2022 Feb; 14(2):e21931. PubMed ID: 35273872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal Treatment of Extragonadal Choriocarcinoma with Multiple Brain and Lung Metastases: A Case Report.
    Uematsu M; Kanemasa Y; Nakamura S; Funasaka C; Kageyama A; Shimoyama T; Omuro Y
    Case Rep Oncol; 2019; 12(3):928-934. PubMed ID: 32110211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
    Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
    World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two Cases of Germ Cell Tumors with Hyperthyroidism Due to High Serum hCGLevels].
    Chihara I; Nitta S; Kimura T; Kandori S; Kawahara T; Waku N; Kojima T; Joraku A; Miyazaki J; Iwasaki H; Suzuki H; Kawai K; Nishiyama H
    Hinyokika Kiyo; 2016 Sep; 62(9):489-493. PubMed ID: 27760975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
    Cafferty FH; White JD; Shamash J; Hennig I; Stenning SP; Huddart RA;
    Eur J Cancer; 2020 Mar; 127():139-149. PubMed ID: 32007714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment outcome and cost-effectiveness analysis of two chemotherapeutic regimens (BEP vs. VIP) for poor-prognosis metastatic germ cell tumors.
    Attili VS; Chandra RC; Anupama G; Loknath D; Bapsy PP; Dadhich HK; Babu GK
    J Cancer Res Ther; 2007; 3(3):150-2. PubMed ID: 18079577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.